Menu
Christoph Twesten
CTO, Founder
Christoph is a physician and technologist at heart. Before helping to found Perfood, Christoph focused on patient care at one of Germany’s leading university hospitals. However, he has always been passionate about the intersections of technology and healthcare. Since childhood he has been building software and engaging with its applications. Within Perfood, Christoph leads our teams for patient-centric digital therapeutics development. With his focus and attention to detail, Christoph has championed the development of our patent pending Nutrilytics™ technology.
Torsten Schröder
Chief Medical Officer, Founder
Torsten holds PhD degrees in both medicine and molecular biology. He has overseen numerous clinical trials and published many research papers in respected journals. At Perfood, Torsten leads our research and development department through rigorous clinical studies - and he is focusing on translating these cutting-edge results into state-of-the-art digital therapies. Torsten is collaborative and engaged; he is keen to overcome hard challenges in order to provide the best possible healthcare for people. He has gained important experiences and insights through his work with leading academic institutions in Germany, Spain, Australia and the USA.
Dominik Burziwoda
CEO, Founder
Dominik leads Perfood as our CEO. He pursues every endeavor with curiosity, creativity and discipline. He combines these personal qualities with a strong focus on rigorous analysis as the foundation and drive for solving complex problems. Dominik holds degrees in quantitative finance and law and has over 10 years of experience in investment and management. As CEO, Dominik also oversees regulatory compliance and sustainable development to help patients today and tomorrow.
Meinhard F. Schmidt
Chair of the Advisory Board
Meinhard is an executive and entrepreneur with more than 25 years of international experience in the Med-/BioTech, Life Science and Digital Health industries. He started his career at Philips, followed by ten years at Roche Diagnostics where he held various global senior leadership roles in Diabetes Care, Laboratory- and PoC-Diagnostics. After that he worked as an executive at Straumann Institute, as CEO responsible for the world-wide “Digitalisation” of the dental industry. Since 2011 he is active as Senior Advisor for Start-Ups and Investors; Board Director/Chair in public and private LifeScience and Digital Health companies.
Dr. Oliver Reuss
Advisory Board Member
Oliver is a biologist by training and holds a PhD in molecular biology with a focus on infectious diseases. Oliver spent 5 years in academic research at the Institute of Molecular Infection Biology at the University of Würzburg, Germany. After some time in management consulting, Oliver joined Boehringer Ingelheim in 2008. Among other roles, Oliver established the Business Model and Healthcare Innovation group in 2014. In 2018, Oliver joined the Boehringer Ingelheim Venture Fund in the newly created Digital Healthcare investment area.
Jochen Brüggen
Advisory Board Member
Jochen is personally liable partner of H.+J. Brüggen KG, a family-owned company in Lübeck with more than 135 years of tradition, over 2,000 employees and a turnover in the mid three-digit millions. He is honorary consul of the Republic of Austria, chairman of the FoodRegio Association, board member of the Lübeck Chamber of Industry and Commerce and the Lübeck Employers' Association. He has a degree in engineering.
Nick Vetter
Advisory Board Member
Nick represents the family office UV-Cap of the Vetter family from Ravensburg in the advisory board of Perfood. He is also CEO of the skin cancer startup OncoBeta. Previously, he gained experience at Danaher in Amsterdam. He studied Physiology in Boulder, Colorado and holds an MBA from SDA Bocconi, Milan.
Michael Lütolf
Board Observer
Michael is an investment manager at Verve Ventures. Michael studied biotechnology and biomedical engineering at ETH Zurich and Columbia University in New York. Before joining Verve Ventures, he worked for two years at Creathor Ventures in Frankfurt and Berlin.
